<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Newsome RC</submitter><funding>NCATS NIH HHS</funding><funding>UF Health Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript</funding><pagination>1-15</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8205023</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(1)</volume><pubmed_abstract>To investigate the relationship between intestinal microbiota and SARS-CoV-2-mediated pathogenicity in a United States, majority African American cohort. We prospectively collected fecal samples from 50 SARS-CoV-2 infected patients, 9 SARS-CoV-2 recovered patients, and 34 uninfected subjects seen by the hospital with unrelated respiratory medical conditions (controls). 16S rRNA sequencing and qPCR analysis was performed on fecal DNA/RNA. The fecal microbial composition was found to be significantly different between SARS-CoV-2 patients and controls (PERMANOVA FDR-&lt;i>P&lt;/i> = .004), independent of antibiotic exposure. &lt;i>Peptoniphilus, Corynebacterium&lt;/i> and &lt;i>Campylobacter&lt;/i> were identified as the three most significantly enriched genera in COVID-19 patients compared to controls. Active</pubmed_abstract><journal>Gut microbes</journal><pubmed_title>The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort.</pubmed_title><pmcid>PMC8205023</pmcid><funding_grant_id>UL1 TR001427</funding_grant_id><funding_grant_id>TL1 TR001428</funding_grant_id><pubmed_authors>Abraham GE</pubmed_authors><pubmed_authors>Gharaibeh RZ</pubmed_authors><pubmed_authors>Jobin C</pubmed_authors><pubmed_authors>Gauthier J</pubmed_authors><pubmed_authors>Sloan M</pubmed_authors><pubmed_authors>Newsome RC</pubmed_authors><pubmed_authors>Wilson KJ</pubmed_authors><pubmed_authors>Senitko M</pubmed_authors><pubmed_authors>Parker A</pubmed_authors><pubmed_authors>Pride Y</pubmed_authors><pubmed_authors>Laird H</pubmed_authors><pubmed_authors>Robinson TO</pubmed_authors><pubmed_authors>Christian T</pubmed_authors><pubmed_authors>Williams HB</pubmed_authors><pubmed_authors>Owings A</pubmed_authors><pubmed_authors>Hernandez MC</pubmed_authors><pubmed_authors>Glover SC</pubmed_authors><pubmed_authors>Hasan M</pubmed_authors></additional><is_claimable>false</is_claimable><name>The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort.</name><description>To investigate the relationship between intestinal microbiota and SARS-CoV-2-mediated pathogenicity in a United States, majority African American cohort. We prospectively collected fecal samples from 50 SARS-CoV-2 infected patients, 9 SARS-CoV-2 recovered patients, and 34 uninfected subjects seen by the hospital with unrelated respiratory medical conditions (controls). 16S rRNA sequencing and qPCR analysis was performed on fecal DNA/RNA. The fecal microbial composition was found to be significantly different between SARS-CoV-2 patients and controls (PERMANOVA FDR-&lt;i>P&lt;/i> = .004), independent of antibiotic exposure. &lt;i>Peptoniphilus, Corynebacterium&lt;/i> and &lt;i>Campylobacter&lt;/i> were identified as the three most significantly enriched genera in COVID-19 patients compared to controls. Active</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jan-Dec</publication><modification>2026-05-01T03:17:05.83Z</modification><creation>2022-02-10T17:36:44.028Z</creation></dates><accession>S-EPMC8205023</accession><cross_references><pubmed>34100340</pubmed><doi>10.1080/19490976.2021.1926840</doi></cross_references></HashMap>